Also, Yu et al. demonstrated that human full-length sclerostin knock-in (hSOSTki) suppressed the progression of AA and atherosclerosis and significantly decreased the expression of inflammatory cytokines and chemokines in hSOSTki.ApoE−/− mice [9]. Here, SOST is linked to atherosclerosis.